Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07727954) titled 'Efficacy and Safety of a Combined Topical Formula Versus Placebo in Patients With Melasma' on July 22.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: University of Guadalajara
Condition:
Melasma
Intervention:
Drug: Topical azelaic acid 12% plus tranexamic acid 5%
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: June 12, 2026
Target Sample Size: 40
Countries of Recruitment:
Mexico
To know more, vis...